Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/146943
Title: New approaches to treat Alzheimer Disease
Author: Tejedor Estrada, Elisenda
Keywords: Malaltia d'Alzheimer
Malalties neurodegeneratives
Alzheimer's disease
Neurodegenerative diseases
Issue Date: Nov-2019
Abstract: A few months ago, a promising study about Alzheimer Disease (AD), a type of dementia, was published in JACC (Journal of the American College of Cardiology). Dementia affects around 50 million people worldwide and around 60-70% of them suffer AD. It is estimated that in 2050 there will be more than 115 million people diagnosed (WHO, 2019). Dementia is a disease that damages cognitive capacity interfering in daily activities. AD is a progressive dementia that worsens through time and lasts around 10-12 years, when the patient dies due to infections or other organic failure...
Note: Premis Pharmanews-Fedefarma 2019
URI: http://hdl.handle.net/2445/146943
Appears in Collections:Premis Fedefarma: Concòrdia / Pharmanews (Facultat de Farmàcia i Ciències de l'Alimentació)

Files in This Item:
File Description SizeFormat 
3-Elisenda Tejedor Estrada-New approaches to treat Alzheimer Disease.pdf117.53 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons